99 related articles for article (PubMed ID: 12847139)
1. Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell function.
Lim DG; Slavik JM; Bourcier K; Smith KJ; Hafler DA
J Exp Med; 2003 Jul; 198(1):99-109. PubMed ID: 12847139
[TBL] [Abstract][Full Text] [Related]
2. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.
Bieganowska K; Höllsberg P; Buckle GJ; Lim DG; Greten TF; Schneck J; Altman JD; Jacobson S; Ledis SL; Hanchard B; Chin J; Morgan O; Roth PA; Hafler DA
J Immunol; 1999 Feb; 162(3):1765-71. PubMed ID: 9973440
[TBL] [Abstract][Full Text] [Related]
3. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
5. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
[TBL] [Abstract][Full Text] [Related]
6. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
[TBL] [Abstract][Full Text] [Related]
7. The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.
Khan AR; Baker BM; Ghosh P; Biddison WE; Wiley DC
J Immunol; 2000 Jun; 164(12):6398-405. PubMed ID: 10843695
[TBL] [Abstract][Full Text] [Related]
8. Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors.
Baker BM; Ding YH; Garboczi DN; Biddison WE; Wiley DC
Cold Spring Harb Symp Quant Biol; 1999; 64():235-41. PubMed ID: 11232291
[No Abstract] [Full Text] [Related]
9. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
10. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
[TBL] [Abstract][Full Text] [Related]
11. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2.
Garboczi DN; Utz U; Ghosh P; Seth A; Kim J; VanTienhoven EA; Biddison WE; Wiley DC
J Immunol; 1996 Dec; 157(12):5403-10. PubMed ID: 8955188
[TBL] [Abstract][Full Text] [Related]
12. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
[TBL] [Abstract][Full Text] [Related]
13. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
[TBL] [Abstract][Full Text] [Related]
14. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
van Buuren MM; Dijkgraaf FE; Linnemann C; Toebes M; Chang CX; Mok JY; Nguyen M; van Esch WJ; Kvistborg P; Grotenbreg GM; Schumacher TN
J Immunol; 2014 Jan; 192(2):641-8. PubMed ID: 24342804
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for HLA-A2 supertypes.
Kangueane P; Sakharkar MK
Methods Mol Biol; 2007; 409():155-62. PubMed ID: 18449998
[TBL] [Abstract][Full Text] [Related]
16. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
17. Unique T cell proliferation associated with PKCmu activation and impaired ZAP-70 phosphorylation in recognition of overexpressed HLA/partially agonistic peptide complexes.
Irie A; Chen YZ; Tsukamoto H; Jotsuka T; Masuda M; Nishimura Y
Eur J Immunol; 2003 Jun; 33(6):1497-507. PubMed ID: 12778467
[TBL] [Abstract][Full Text] [Related]
18. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996. 384: 134-141.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
J Immunol; 2010 Dec; 185(11):6394-401. PubMed ID: 21084668
[No Abstract] [Full Text] [Related]
19. A structural basis for immunodominant human T cell receptor recognition.
Stewart-Jones GB; McMichael AJ; Bell JI; Stuart DI; Jones EY
Nat Immunol; 2003 Jul; 4(7):657-63. PubMed ID: 12796775
[TBL] [Abstract][Full Text] [Related]
20. Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2.
Weng X; Liang Z; Lu X; Zhong M; Lu S; Zhang C; Deng J; Wu X; Gong F
Sci China C Life Sci; 2007 Apr; 50(2):203-11. PubMed ID: 17447027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]